Advert - AstraZeneca

• Date posted
  01 November 2016
• Sanction
  Advertisement,
• Case number/s
  AUTH/2842/4/16 - Anonymous v AstraZeneca

For facilitating the use by independent speakers of uncertified presentations which were misleading as to the licensed indication for Duaklir Genuair (formoterol/aclidinium), AstraZeneca was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Clause 3.2 - Implying a use for a medicine which was inconsistent with its summary of product characteristics.

Clause 7.2 - Being misleading as to the licensed indications of medicines.

Clause 9.1 - Failing to maintain high standards.

The full case report was published in the PMCPA November 2016 Code of Practice Review and it is available at www.pmcpa.org.uk.